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INTRODUCTION
Atrial natriuretic factor (ANF) is a key
regulator of cardiovascular and renal
function, but compelling evidence sup-
ports its physiological role in the diges-
tive system where it modulates digestive
motility and secretions in a paracrine
and/or autocrine manner (1–4). We pre-
viously reported that ANF through natri-
uretic peptide receptor type C (NPR-C)
receptors coupled to phospholipase C/
protein kinase C (PLC/PKC) negatively
modulates secretin intracellular signaling
by stimulating secretin-evoked cAMP
out of the pancreatic acinar cells through
multidrug resistance-associated protein 4
(MRP4) (5,6). MRP4 (ATP-binding cas-
sette sub-family C member 4 [ABCC4]) 
is a member of the multidrug resistance
proteins (MRPs) belonging to the 
C group of the ATP-binding cassette
(ABC) protein superfamily, which func-
tions as an energy-dependent, trans-
membrane efflux transporter. Com-
pelling evidence supports that cAMP
extrusion through MRP4 in several cell
types provides a complementary mecha-
nism to the phosphodiesterases (PDEs)
as modulators of the intracellular con-
centration of the second messenger
(6–10). In isolated pancreatic acini, we
found that secretin- induced cAMP is ex-
truded by ANF through NPR-C recep-
tors coupled to the PLC/PKC pathway,
thus restricting its intracellular accumu-
lation. This mechanism operates in the
presence of active PDEs supporting that
cAMP extrusion through MRP4 might be
a mechanism in addition to PDE action
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to regulate intracellular cAMP levels in
pancreatic acinar cells. In addition, we
showed that in vivo cAMP is released in
the bloodstream in response to secretin
and that this effect is further enhanced
and sustained by ANF supporting the
physiological role of ANF in the modu-
lation of intracellular cAMP levels in the
exocrine pancreas (6).
Tight regulation of cAMP production
within cells leads to avoidance of over-
stimulation of certain secretory events,
deregulation of cell function or even cell
toxicity. In pancreatic acinar cells, se-
cretin as well as other agents that in-
crease cAMP have little effect on zymo-
gen activation alone but sensitize the
response of agents that increase intracel-
lular calcium such as cerulein or chole-
cystokinin (11,12). In pancreatic acini, it
was reported that a cell-permeable
cAMP inhibitor (Rp-8Br-cAMP) reduces
the sensitization induced by vasoactive
intestinal peptide and 8Br-cAMP to low
and high doses of cerulein (11). It also re-
duces chymotrypsin activation induced
by high doses of cerulein alone. It was
proposed that agonists that augment
cAMP formation in the acinar cell may
predispose the cell to pathophysiological
zymogen activation and contribute to the
development of acute pancreatitis. There-
fore, it is possible that ANF, by limiting
cAMP intracellular levels, is somehow
protecting eventual premature zymogen
granule activation within the acini.
Acute pancreatitis is a sudden inflam-
matory disorder of the exocrine pancreas
that, in its severe form, carries consider-
ably morbidity and mortality. Pancreatic
injury is caused by the premature activa-
tion of digestive enzymes that the pan-
creas normally produces, although the
early events involved in the onset of the
disease still remain obscure (13). Recent
studies show that impaired autophagy
mediates acinar cell vacuole formation
and trypsinogen activation (14,15). The
combined autophagic, lysosomal and mi-
tochondrial dysfunctions are considered
key to the pathogenesis of the disease (15).
In the present study, we sought to es-
tablish whether the extrusion of cAMP
by ANF would play a beneficial role in
vivo by avoiding and/or attenuating the
onset of acute pancreatitis in the rat.
MATERIALS AND METHODS
Animals and Reagents
Sprague Dawley rats (180–200 g) were
housed in steel cages and maintained at
22–24°C in a controlled room with a 12-h
light–dark cycle (light from 0700 to 1900).
All experimental protocols were ap-
proved by the Animal Care Committee
of the School of Pharmacy and Biochem-
istry of the University of Buenos Aires.
All procedures complied with the recom-
mendations of the Guidelines for the Care
and Use of Laboratory Animals (National
Institutes of Health publication N85-23,
1985, ref. [16]; revised 1996, ref. [17]). All
reagents were purchased from Sigma-
Aldrich (St. Louis, MO) unless otherwise
stated.
Experimental Protocols
Animals were fed standard animal lab-
oratory chow, given water ad libitum,
fasted overnight and randomly assigned
to control or experimental groups. First
we addressed whether secretin and ANF
affected pancreatic enzymatic activity
and/or morphology in normal and
pathophysiological conditions. For this
purpose, animals were infused with
saline (control), secretin (1 U/kg/h) or
ANF (1 μg/kg/h) alone or combined for
60 min. The doses of secretin and ANF
were obtained from previous dose-
 response curves (3). In another group of
rats, acute pancreatitis was induced by
four repetitive intraperitoneal injections
of 40 μg/kg cerulein at hourly intervals
and secretin infusion alone, or with ANF
for 60 min starting 30 min before the first
cerulein injection. Saline-administered
animals served as controls. To evaluate
the role of MRPs, a set of animals was
pretreated with 0.5 mL probenecid
(50 mg/kg intraperitoneally) (MRP in-
hibitor) 60 min before ANF and secretin
infusion or acute pancreatitis induction.
Probenecid was made up in a minimal
volume of 1 mol/L NaOH until dis-
solved and was then diluted in saline,
and the pH was adjusted to 7.4. Control
animals received probenecid vehicle. An-
imals were killed by decapitation at 1 h
after the last cerulein injection, and blood
and pancreatic tissue samples were har-
vested for enzymatic determinations and
histology.
Additional experiments were per-
formed in isolated pancreatic acini pre-
treated with 50 μmol/L MK571 (MRPs
inhibitor) or 1 mmol/L probenecid for 30
min and further exposed to 100 nmol/L
secretin for 10 min. After incubation with
secretin, intracellular cAMP and intra-
pancreatic trypsin were assayed as de-
tailed below. Pancreatic acini were iso-
lated by enzymatic digestion as
previously reported (6,18).
Enzymatic Determinations
Plasma amylase activity was measured
by using chloro-p-nitrophenyl-α-D-
 maltotrioside as substrate (Wiener Labo-
ratories, Rosario, Argentina). Trypsin ac-
tivity was fluorometrically determined as
previously detailed by using the specific
substrate Boc-Gln-Ala-Arg-MCA (Pep-
tide International, Louisville, KY, USA).
Briefly, pancreas was homogenized in
cold (4°C) buffer (250 mmol/L sucrose,
5 mmol/L 3-(N-morpholino)propanesul-
fonic acid (MOPS), 1 mmol/L MgSO4,
pH 6.5) by using a Teflon-coated homog-
enizer and then centrifuged at 150g for
10 min at 4°C. Duplicate aliquots of each
supernatant were added to a 48-well tis-
sue culture plate containing 350 μL of
trypsin assay buffer (50 mmol/L Tris [pH
8.1], 150 mmol/L NaCl, 1 mmol/L CaCl2,
0.01% bovine serum albumin [BSA]), and
then 10 mmol/L enzyme substrate was
added to each well. Accumulation of flu-
orescence was measured over 11 min by
using a fluorescent microtiter plate
reader (FlexStation III; Molecular De-
vices, Sunnyvale, CA, USA) at 380 nm
excitation and 440 nm emission wave-
lengths. Enzymatic activity was ex-
pressed as percentage of control.
Histological examination of pancreatic
tissue: For light microscopy studies, pan-
creatic tissue was fixed in 10% buffered
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formaldehyde, embedded in paraffin,
sectioned and stained with hematoxylin
and eosin (17). The pancreas of at least
five rats from each group was examined
for vacuolization, inflammation, edema,
necrotic areas and pyknotic nuclei (mor-
phological marker of apoptosis) by a
pathologist blinded to the experimental
protocol. The quantitative evaluation
was performed using a modified score
previously described (17,18). The sec-
tions (a minimum of five fields with
400× magnification) were examined for
each sample and scored on a scale of 0–4
based on the percentage of area with the
presence of vacuoles, zymogen granules,
edema and vascular congestion. The
highest percentage was assigned as 4.
The percentage of pyknotic nuclei and
necrotic areas were evaluated per field
(minimum of 12 fields) with 1,000× mag-
nification. Cells with swollen cytoplasm,
loss of plasma membrane integrity and
absent nucleus were considered necrotic
and evaluated per field (minimum of 12
fields) with 1,000 magnification.
Measurement of cAMP
A set of animals pretreated with
probenecid were infused with secretin
alone or with ANF, and blood samples
were collected at different time points (0,
3, 5, 10, 15 and 30 min) as previously de-
tailed (6). Blood samples were rapidly
centrifuged, and plasmas were collected
in ethanol and stored at –20°C. Samples
were dried and the remaining residue
was suspended for cAMP determination,
assessed by competition of [3H]cAMP for
PKA as previously detailed (9,19). Re-
sults were expressed as picomoles per
milliliter plasma. Determination of
cAMP in pancreatic acini was expressed
as percentage of control and performed
as in previous studies (3,5,6).
Immunofluorescence for MRP4
For MRP4 immunolocalization, pancre-
atic tissue sections in paraffin were
soaked in xylol and hydrated with de-
creasing concentrations of alcohol (100%
to 96% to 70%). Sections were then
treated with 5% BSA in phosphate-
buffered saline (PBS) (blocking solution),
followed by incubation with primary an-
tibody against MRP4 (Alexis Biochemi-
cals [Enzo Life Sciences Inc., Farming-
dale, NY, USA]) (1:300). Slides were
washed in PBS, incubated with secondary
antibody Cy3-conjugated anti-rabbit
(Jackson ImmunoResearch Laboratories,
Inc., West Grove, PA, USA) at a dilution
of 1:500 and coverslipped with Vec-
tashield (Vector, Burlingame, CA, USA).
The stained samples were then examined
by using a fluorescence microscope
(Olympus BX50; Olympus Corporation,
Tokyo, Japan) with appropriate filter sets.
Statistical Analysis
Results are expressed as the mean ±
standard error of the mean. Statistical
analysis was performed by analysis of
variance followed by the Student-New-
man-Keuls test. A p value ≤0.05 was con-
sidered statistically significant.
All supplementary materials are available
online at www.molmed.org.
RESULTS
MRP4 Is Localized to the Basolateral
Membrane of Acinar Cells and
Mediates cAMP Efflux In Vivo
We previously reported that the infu-
sion of secretin increases plasma cAMP
and that this response is enhanced and
sustained in the presence of ANF, sug-
gesting that the cyclic nucleotide is re-
leased into the bloodstream presumably
through MRP4, which is the major trans-
porter for the second messenger in pan-
creas as revealed by siRNA studies (6).
We also showed by reverse transcrip-
tase–polymerase chain reaction (RT-PCR)
and Western blot analyses that MRP4
mRNA and protein are expressed in the
rat pancreas; however the localization of
MRP4 in the acinar cell was unknown.
Immunofluorescence showed that the
transporter was localized to the basolat-
eral membrane of pancreatic acinar cells
(Figure 1A).
To evaluate in vivo the role of MPRs,
animals were pretreated with
probenecid and further infused with se-
cretin alone or with ANF. Although
probenecid is a general MRP inhibitor,
previous studies silencing MRP4 by
siRNA revealed that it is the major
cAMP efflux transporter in the exocrine
pancreas (6). Blockade of MRPs by
probenecid prevented the increase in
plasma cAMP induced by secretin alone
or with ANF, suggesting that the release
of the cyclic nucleotide to the blood-
stream is mediated by MRPs, likely
MRP4 (Figure 1B). The temporal course
of cAMP in each experimental group is
shown in the left panel of Figure 1B,
whereas the area under each curve is
presented in the right panel.
Role of ANF and MRPs in Normal Rats
We next evaluated whether blockade
by probenecid affected zymogen activa-
tion and pancreatic histology. Plasma
amylase activity was not modified by
probenecid alone or followed by the in-
fusion of secretin alone or with ANF
(Supplementary Figure S1). However,
trypsin activity was enhanced by secretin
alone and in probenecid-treated rats in-
fused either with secretin or secretin and
ANF (Figure 2A). Microscopy studies
showed a higher density of apical zymo-
gen granules in acinar cells from animals
with ANF and secretin (Table 1 and Sup-
plementary Figures S2A–C). Probenecid
alone did not induce histological changes
in the pancreas (Figure 3B), but in the
presence of secretin alone or with ANF,
vacuoles in acinar cells were observed
(Table 1 and Figures 3D, E), which corre-
lated well with intrapancreatic trypsin el-
evation (Figure 2A). In the absence of
probenecid, secretin alone enhanced
trypsin, although it was not accompa-
nied by pancreatic histological changes
(Supplementary Figure S2B). Secretin-in-
duced trypsinogen activation was pre-
vented by ANF (Figure 2A). An increase
in pyknotic nuclei was observed in all
ANF-treated rats including those pre-
treated with probenecid, suggesting that
the atrial peptide stimulates apoptosis
independently of its effect on cAMP ef-
flux (Table 1).
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Correlation between Intracellular
cAMP and Trypsinogen Activation in
Isolated Pancreatic Acini
Because probenecid is a general MRP
inhibitor and to further confirm the par-
ticipation of MRP4, isolated pancreatic
acini were pretreated with MK571, which
is more specific than probenecid because
it inhibits MRP4 and no other MRPs in-
volved in cAMP efflux (22,23). MK571
mimicked probenecid response, and they
both further enhanced the increase in in-
tracellular cAMP and trypsin evoked by
secretin, showing that higher intracellular
cAMP correlates with higher trypsinogen
activation as found in in vivo studies (Fig-
ures 2B, C). These findings support that
increased intracellular cAMP induced by
secretin or secretin and MRP4 blockade
results in zymogen activation.
Role of ANF in Rats with Acute
Pancreatitis
We then evaluated the role of ANF in
an animal model of acute pancreatitis in-
duced by repetitive injections of cerulein.
Results showed that cerulein-treated rats
showed elevation of plasma amylase as
well as intrapancreatic trypsin activity
(Figures 4A, B) and histological features
of acute pancreatitis such as vacuoliza-
tion, edema and areas of necrosis as pre-
viously reported (Table 2 and Figure 5A).
That secretin infusion aggravated acute
pancreatitis was supported by the obser-
vation of a further increase in plasma
amylase and trypsin activity as well as
by the enhanced loss of acini architec-
ture, higher vacuolization, more areas of
necrosis and important interstitial edema
(Table 2 and Figure 5C). The infusion of
ANF ameliorated acute pancreatitis sup-
ported by reduced plasma amylase and
trypsin activities (Figures 4A, B). ANF
also enhanced apoptosis, and although it
did not prevent vacuolization, less num-
ber of vacuoles were observed (Table 2
and Figure 5D).
Role of ANF and MRP Blockade in Rats
with Acute Pancreatitis
We next addressed the role of MRPs
and ANF in probenecid-treated rats with
Figure 1. (A) MRP4 is localized to the basolateral membrane of acinar cells. MRP4 was de-
termined by immunofluorescence as detailed in Materials and Methods. Immunofluores-
cence was concentrated in the basolateral membrane of acinar cells (left panel); nega-
tive control is shown (right panel). (B) MRP4 inhibition abolishes plasma cAMP increase
evoked by secretin and ANF. Animals were pretreated with or without probenecid fol-
lowed by infusion with secretin alone or with ANF; blood samples were withdrawn at 3, 5,
10, 15 and 30 min and cAMP was assessed by radioimmunoassay as described in Materi-
als and Methods. Right panel: time course of cAMP after the different treatments. □, Con-
trol; ■, ANF; ▲, secretin; ●, secretin + ANF. Dotted lines represent the same groups treated
with probenecid. Left panel: Area under each temporal curve. **p < 0.01 and ***p < 0.001
versus control; #p < 0.05 versus secretin; ##p < 0.01 versus secretin + ANF. Scale bar, 20 μm.
Figure 2. (A) MRP4 inhibition further increases secretin-induced zymogen activation. Intrapan-
creatic trypsin was fluorometrically assessed in animals pretreated with probenecid followed
by the infusion of secretin alone or with ANF. *p < 0.05 and ***p < 0.001 versus control; #p =
0.05 versus secretin. Number of experiments: 5. (B, C) Blockade of MRPs with MK571 mimics
probenecid response in the presence of secretin. Isolated pancreatic acini were pretreated
with probenecid or MK571 and further exposed to secretin. Intrapancreatic trypsin (B) and in-
tracellular cAMP (C) were assayed as detailed in Materials and Methods. S, secretin.
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acute pancreatitis. When animals were
pretreated with probenecid followed by
cerulein injections, MPRs blockade re-
sulted in further aggravation of the dis-
ease compared with cerulein-treated rats
(Figures 5E–H and Table 2). Trypsin ac-
tivity was elevated and further increased
in the presence of secretin (Figure 4B).
Histological studies supported aggrava-
tion of acute pancreatitis. Loss of pancre-
atic acini architecture was clearly ob-
served in all groups but was further
enhanced in those groups that received
secretin alone or with ANF (Table 2). In-
creased areas of necrosis, edema and vas-
cular congestion were evident together
with enhanced vacuolization (Figures 5G
and 6H). Larger vacuoles with cytoplas-
mic content and zymogen granules dis-
persed in the cytoplasm were observed
(Table 2). ANF failed to inhibit secretin
response or to ameliorate acute pancre-
atitis, suggesting that the beneficial effect
of the peptide is likely mediated by stim-
ulating cAMP efflux through MRPs. In
ANF-treated animals, an increased num-
ber of pyknotic nuclei was also observed
and did not depend on MRP blockade.
DISCUSSION
The major finding of the present work
is that blockade of MRPs makes the ex-
ocrine pancreas of normal rats prone to
injury; further, it aggravates acute pan-
creatitis as supported by biochemical and
histological studies, suggesting that en-
hanced intracellular cAMP levels in the
onset of the disease clearly favors the
damage of the exocrine pancreas. ANF
seems to have a beneficial effect by stim-
ulating cAMP extrusion and by presum-
ably enhancing apoptosis.
The present study confirms that MRP4
is localized to the basolateral membrane
of acinar cells. MRP4 differs from other C
subfamily members because of its dual
localization in polarized cells. In hepato-
cytes, choroid plexus epithelium and
prostate tubuloacinar cell MRP4 is local-
ized to the basolateral membrane,
whereas in renal proximal tubular cells, it
is in the apical membrane (24,25). The ba-
solateral localization of MRP4 in pancre-
atic acinar cells is in accordance with
plasma cAMP elevation in response to se-
cretin alone or with ANF. Secretin recep-
tors are also expressed in duct cells, so it
is likely that this cell type may contribute
to the response and to a less extent other
cells expressing both secretin receptors
and MRP4. Although previous studies in
human pancreas and pancreatic carci-
noma show that MRP4 is also localized in
duct cells, we failed to detect the trans-
porter in this cell type in the rat (26).
We first evaluated in vivo the effect of
ANF on intrapancreatic enzymatic acti-
Table 1. Histological examination of the exocrine pancreas with or without probenecid (P)
pretreatment and infused with secretin (S) alone or with ANF.
Apical Vascular Necrotic Pyknotic 
granules Edema congestion Vacuoles areas/field nuclei/field
Control 2 0 0 0 0 0–1
ANF 2 0 0 0 0 1
Secretin 4 0 0 0 0 0–1
S + ANF 4 0 0–1 0 0 1
Probenecid 2 0 0 0 0 0–1
P + ANF 2 0 0–1 0–1 0–1 1
P + S 3 0–1 0 1 0–1 0–1
P + S + ANF 2–3 0–1 0 1 0–1 1–2
Figure 3. Blockade of MRPs induces vacuole formation in acinar cells of secretin-treated
rats. Hematoxylin and eosin sections of pancreas from control (A), probenecid (B),
probenecid + ANF (C), probenecid + secretin (D) and probenecid + secretin + ANF (E)
are shown. Small and large vacuoles were observed in groups D and E (arrowheads).
Each is a representative photograph (400× magnification).
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vation and histological changes in the
presence or absence of secretin. The hor-
mone alone enhanced intrapancreatic
trypsin activity, but no pancreatic histo-
logical changes were associated. ANF
blunted secretin response, suggesting
that the atrial peptide may play a protec-
tive role to avoid premature enzyme acti-
vation within the acinar cell and even-
tual gland damage. The activation of
trypsinogen is one of the earliest events
known to be one of the key steps of pro-
tease activation in acute pancreatitis. In-
appropriate intracellular activation of
trypsinogen in turn activates a cascade of
phospholipases, elastases and other me-
diators with increased neutrophil migra-
tion to the pancreas and subsequent re-
lease of inflammatory cytokines that
propagate inflammation and tissue dam-
age. Although enhanced trypsinogen ac-
tivation was not accompanied by evident
histological alterations in the present
study, increased trypsin is a critical initi-
ating event of acute pancreatitis.
To determine whether the ANF protec-
tive role was mediated by stimulated
cAMP extrusion through MRP4, animals
were pretreated with a MPR inhibitor.
Probenecid is a general MRP inhibitor,
but our previous studies silencing MRP4
by siRNA supported that MRP4 was re-
sponsible for cAMP efflux in the exocrine
pancreas, as shown in other tissues (6).
Blockade of MRPs by probenecid pre-
vented the increase in plasma cAMP
after secretin infusion alone or with ANF,
suggesting that the release of the second
messenger to the bloodstream is medi-
ated by MRP4. We previously reported
that after secretin infusion alone, plasma
cAMP increased by 60% over control val-
ues at 3 min, peaked at 5 min (168%) and
then declined to control values at 15 min.
However, when ANF was co-infused, the
increase in plasma cAMP was higher and
more sustained than with secretin alone,
although the peak was reached later (10
versus 5 min) as well as control values
(30 versus 15 min) (6).
Blockade of MRPs in secretin-treated
rats further increased trypsinogen activa-
tion, which correlated with the appear-
ance of cytoplasmic vacuoles in pancre-
atic acinar cells, a hallmark of acute
pancreatitis. In accordance, in isolated
pancreatic acini, blockade of MRPs by
probenecid or MK571 further enhanced
secretin-evoked increases in intracellular
cAMP and trypsinogen activation, sup-
porting that elevated cAMP in acinar
cells induce zymogen activation. Find-
ings in the presence of MK571 supports
the participation of MRP4 and excludes
the contribution of MRP5 and MRP8,
which is expressed in the exocrine pan-
creas and has been associated with
cAMP efflux in other cell types.
ANF failed to inhibit secretin response
in probenecid-pretreated rats, support-
ing that ANF protects the pancreas from
injury by stimulating cAMP efflux.
These findings further suggest that
cAMP extrusion would play a relevant
role in maintaining pancreatic acinar cell
homeostasis.
We next evaluated the role of ANF and
MRP blockade in acute pancreatitis.
Cerulein-treated rats showed elevation of
plasma amylase and intrapancreatic
trypsin as well as morphological alter-
Figure 4. (A) MRPs inhibition prevents ANF-induced reduction of plasma amylase in the
presence or absence of secretin in acute pancreatitis. Animals were infused with secretin
alone or with ANF, acute pancreatitis was induced by repetitive cerulein injections and
amylase was measured in plasma as detailed in Materials and Methods. White bar:
cerulein alone. *p < 0.05 versus cerulein; #p < 0.05 versus secretin. Number of experiments:
6. The dotted line represents plasma amylase average value in normal rats. (B) MRP inhibi-
tion prevents ANF-induced reduction of zymogen activation in the presence or absence
of secretin in acute pancreatitis. Trypsin activity was fluorometrically assessed in pancreas
from animals with acute pancreatitis infused with secretin alone or with ANF, as detailed in
Materials and Methods. White bar: cerulein alone. **p < 0.01 and ***p < 0.001 versus con-
trol; †p < 0.05 versus cerulein; #p < 0.05 versus secretin. Results are expressed as percent-
age of control. Number of experiments: 5.
Table 2. Histological examination of the exocrine pancreas in cerulein-treated rats (C)
pretreated with secretin (S) alone or with ANF in the absence or presence of probenecid (P).
Apical Vascular Necrotic Pyknotic 
granules Edema congestion Vacuoles areas/field nuclei/field
C 1–2 1 2 1–2 2 1–2
C + ANF 1–2 1–2 2–3 1–2 2 2–3
C + S 1–2 3 4 2 2–3 1–2
C + S + ANF 1–2 2 2–3 2 3 4
P + C 1–2 1 2 1–2 2 1–2
P + C + ANF 1 2 3 3 3–4 4
P + C + S 1 4 4 4 3–4 2
P + C + S + ANF 1 4 4 4 4 4
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ations of the disease such as vacuoliza-
tion, areas of necrosis, pyknotic nuclei
and distortion of the pancreatic acini ar-
chitecture as previously reported (13,14).
Secretin further enhanced enzymatic ac-
tivity and induced more severe morpho-
logical changes in the pancreas. ANF
blunted secretin response and attenuated
acute pancreatitis. However, when ani-
mals were also pretreated with
probenecid, acute pancreatitis was more
severe, with larger necrotic areas, loss of
acini architecture, increased vacuoliza-
tion, edema and vascular congestion as
well as marked distribution of zymogen
granules from the apical membrane. Se-
cretin further aggravated the morpholog-
ical features of acute pancreatitis in rats
with MRP blockade, since larger vac-
uoles with cytoplasmic content as well as
more necrotic areas were clearly ob-
served. However, ANF failed to prevent
secretin response or attenuate the dis-
ease, suggesting that cAMP efflux partly
mediates ANF beneficial effect.
Present results show that elevated in-
tracellular cAMP levels in acinar cells in-
duced by secretin and/or MRP blockade
at the onset of acute pancreatitis would
be deleterious. The morphological and
biochemical features of acute pancreatitis
are aggravated by blocking cAMP efflux.
Further, MRP blockade alone in the pres-
ence of secretin resulted in vacuolization
of the acinar cell and trypsinogen activa-
tion, revealing that intracellular elevation
of cAMP makes the pancreas prone to in-
jury. Although probenecid is not a spe-
cific MRP4 inhibitor, our previous stud-
ies and present findings with MK571
support the relevance of MRP4 in cAMP
regulation.
Previous studies suggest a beneficial
role for cAMP in cerulein-induced acute
pancreatitis. It was reported that cAMP-
stimulated pathway reduces cellular in-
jury by causing secretion of active en-
zymes from pancreatic acinar cells (27).
Furthermore, it was shown that exoge-
nous secretin ameliorates acute pancre-
atitis in rats and dogs (28–31). The ap-
parent discrepancy with our study may
be related to the time course of cAMP in-
Figure 5. Secretin aggravates cerulein-induced acute pancreatitis and ANF reduces se-
cretin response, but MRP inhibition further aggravates cerulein-induced acute pancreati-
tis in the presence of secretin and blunts ANF response. (A–D) Hematoxylin and eosin sec-
tion of pancreas from rats with acute pancreatitis induced by cerulein and infused with
secretin alone or with ANF. Control (A), ANF (B), secretin (C), and secretin + ANF (D) are
shown. Higher vacuolization and areas of necrosis were observed in (C). Each is a repre-
sentative photograph (400× magnification). (E–H) Hematoxylin and eosin section of pan-
creas from rats with acute pancreatitis induced by cerulein and infused with secretin
alone or with ANF in the presence of probenecid pretreatment. Probenecid (E),
probenecid + ANF (F), probenecid + secretin (G), and probenecid + secretin + ANF (H)
are shown. Higher areas of necrosis and larger vacuoles were observed in (G) and (H).
Each is a representative photograph (400× magnification).
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tracellular levels and a possible dual role
of the second messenger. In our study se-
cretin, ANF and/or probenecid were ad-
ministered before the induction of acute
pancreatitis, so that cells had elevated
cAMP intracellular levels before the
onset of the disease. In other studies, se-
cretin and other drugs were simultane-
ously given. It is likely that increased in-
tracellular cAMP may be deleterious
when elevated in the onset of the disease
but protective once acute pancreatitis is
triggered.
A recent study show that ductal secre-
tion protects the pancreas from acute
pancreatitis, suggesting that improved
ductal function may help to prevent and
treat the disease (32). However, in our
study, the sole infusion of secretin, which
acts on receptors in acinar and duct cells,
enhanced trypsinogen activation. Fur-
ther, it aggravated acute pancreatitis,
suggesting that secretin-enhanced ductal
function does not prevent the disease.
An interesting finding of the present
study was the observation of a higher
number of pyknotic nuclei in all ANF-
treated animals despite other concomi-
tant treatments. This increase was not
prevented or reduced by probenecid,
suggesting that it is independent of the
ANF effect on MRP4 and cAMP intracel-
lular levels. Stimulation of apoptosis in
acute pancreatitis is beneficial because
the extent of apoptosis has been shown
to be inversely related to the severity of
the disease (33). It has been shown that
the milder forms of experimental pan-
creatitis are associated with more apo-
ptosis, whereas the relatively severe
forms are associated with more necrosis.
Although diverse studies suggest that
ANF stimulates apoptosis, further stud-
ies are needed to evaluate whether the
increase in pyknotic nuclei induced by
ANF represents an additional protective
effect (34).
The role of MRP4 and ANF in acute
pancreatitis may have further implica-
tions related to the inflammatory re-
sponse involved in the pathogenesis of
the disease. Activation of the transcrip-
tion factor nuclear factor (NF)-κB pro-
motes cytokine synthesis, which in turn
upregulates inducible enzymes such as
COX2, leading to the increase in
prostaglandins, responsible for the pro-
gression of inflammation. Accumulating
evidence indicates the essential contribu-
tion of the COX2 pathway to cerulein-
 induced acute pancreatitis because its in-
hibition ameliorates the disease (35,36).
MRP4 has been identified as a trans-
porter for cAMP, but prostaglandins E1
and E2 are also physiological substrates
for MRP4 (36–40). Furthermore, it was
recently shown that MRP4 contributes to
breast cancer progression by exporting
PGE2 (41). Preliminary data from our
laboratory show that intrapancreatic con-
tent of PGE2 is diminished in cerulein-
treated rats infused with ANF, suggest-
ing that the atrial peptide may not only
stimulate cAMP efflux but also PGE2 ex-
trusion, thus regulating the inflamma-
tory response in acute pancreatitis.
Despite extensive studies, acute pan-
creatitis still remains a serious disease. In
most cases, it has a benign course and is
self-limiting and the pancreas fully re-
covers its functionality. However, in
~20% of the patients, it progresses to a
more severe form that can lead to death
due to multiple organ failure. The under-
lying mechanisms that lead to one form
or the other still remain obscure. Our re-
sults support a deleterious effect of ele-
vated cAMP in the onset of acute pancre-
atitis and a beneficial role for ANF by
extruding the second messenger through
MRP4. Whether elevated cAMP intracel-
lular levels in the onset of acute pancre-
atitis conditions the course of the disease
is presently unknown. Figure 6 depicts a
schematic representation of the proposed
actions of ANF, MRP4 and secretin in
pancreatic acinar cells on the basis of
previous and present findings.
Increasing evidence supports the par-
ticipation of MRPs in diverse physiologi-
cal and pathophysiological cellular events
beyond the initially described property of
these transporters linked to antidrug effi-
cacy. Our findings highlight that the clini-
cal use of drugs that modulate MRP ac-
tivity should be carefully evaluated to
avoid undesired effects given the wide
Figure 6. Schematic representation of the proposed action of ANF, secretin and MRP4
(MRP-4) in pancreatic acinar cells. Stimulation of secretin receptors leads to adenylyl cy-
clase activation, and the rise of intracellular cAMP is regulated by the action of PDEs and
the exclusion of the second messenger through MRP4. ANF by activating NRP-C receptors
potentiates cAMP efflux. Marked cAMP elevation as induced by secretin and MRP4
blockade by probenecid or MK571 leads through downstream effectors to trypsinogen
activation and eventual damage of acinar cells. AC, adenylyl cyclase; e-cAMP, extracel-
lular cAMP; i-cAMP, intracellular cAMP; SECRETIN-R, secretin receptor.
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spectrum of differential biological actions
where these transporters are involved.
CONCLUSION
Given the physiological importance of
MRP4 in the regulation of cAMP intra-
cellular levels in pancreatic acinar cells
homeostasis and its modulation by ANF,
impaired activity or altered expression of
MRP4 may affect the onset, course
and/or outcome of acute pancreatitis.
Besides cAMP, MRP4 also effluxes PGE2,
a key player in the inflammatory re-
sponse that features the disease. Because
increasing reports in the literature show
that MRP4 is emerging as a new thera-
peutic target for diverse diseases, it may
represent a therapeutic target for acute
pancreatitis.
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